ORG is taking a solid step towards acquiring CPMC, with receiving SAMR clearance and management selling shares in Huangshan Novel to raise funds. We recommend waiting for Baosteel to raise its Offer.
What is covered in the Full Insight:
Introduction
SAMR Approval and Pre-Conditions
ORG's Financial Strategy
Baosteel's Position and Strategy
Investment Recommendations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.